D.K. Pharmachem Pvt. Ltd.

–CDMO & Contract Manufacturing Services

Four decades of process chemistry, built for your supply chain.

WHO-GMP certified manufacturer of APIs, advanced intermediates and specialty fine chemicals — trusted by Teva, Sanofi, Bayer and Lonza for 15-20 years running.
In operation since
1980
Certification
WHO-GMP
Regulatory approvals
PMDA · EU
Production streams
3 WHO-GMP lines
Longest client relationship
15–20 yrs

45+

Years in pharmaceutical manufacturing

15–20

Years as exclusive supplier to Teva, Sanofi, Bayer & Lonza

8

CEPs filed with EDQM

35

Products with EU Written Confirmation

7

Global regulatory accreditations held

— Why Partner With Us

A supply relationship measured in
decades, not deliverables.

Bringing an API or intermediate to reliable commercial supply takes more than a reaction vessel. It takes a partner who understands regulatory complexity, scales without compromising quality, and stays in it for the long haul.
SCALE
Ready from day one

WHO-GMP certified and ICH Q7A compliant, with active approvals from Japan PMDA and European authorities, plus EU Written Confirmation on 35 products.

SCALE
Proven at commercial volume

Three WHO-GMP certified production streams, regularly audited by leading Indian and multinational firms — not a single-line operation.

CHEMISTRY
Reactions others won’t take on

Dedicated facilities for nitration, chloro-sulfonation, high-pressure oxidation, hydrogenation and more — complex synthesis kept in-house.

SUPPLY CHAIN
Backward & forward integration

We manufacture many of our own key starting materials, giving partners greater control over cost, lead time and continuity of supply.

–CDMO CAPABILITIES

Across the full product lifecycle

From first route scouting to full commercial-scale supply, every stage is managed under one roof and one quality system.

Stage 01

Route Scouting & Process Development

Every project starts with identifying the right synthetic pathway — balancing safety, yield, cost, and ease of scale-up. Our process chemistry team evaluates raw material security, IP considerations, and environmental impact before committing to a route.

Stage 03

Backward & Forward Integration

We manufacture many of our own key starting materials and intermediates rather than relying solely on external suppliers — giving partners greater control over cost, lead time, and supply continuity, from pre-backward integration through forward integration stages.

Stage 04

Analytical & Quality Support

In-house Analytical Method Validation (AMV) and Process Validation (PV), long- and short-term stability studies, and DMF support – all conducted internally with IR, GC, HPLC, UV and Karl Fischer instrumentation, under 21 CFR Part 11 compliant QC systems.

Stage 05

Commercial-Scale Manufacturing

Three dedicated WHO-GMP certified production streams support everything from development quantities through full commercial supply, with a track record of consistent, audited performance for global pharma partners.

–CDMO CAPABILITIES

Recognized by the authorities that matter to your launch markets

Our Quality Management System is built around ICH guidelines and is 21 CFR compliant, with active accreditations across major regulatory markets.

CEP

EDQM, Europe

PMDA

Japan

TGA

Australia

MOH

Ministry of Health

NMPA

China (with CDE)

MFDS

South Korea

AIFA

Italy
–PRODUCT PORTFOLIO

What we manufacture

Active Pharmaceutical Ingredients

Manufactured under WHO-GMP and ISO-certified processes, with PMDA and European regulatory approvals.

VIEW APIs →
Chemical Intermediates

High-purity intermediates including sulphonyl chlorides, amides, acids and derivative.

VIEW APIs →
Specialty Fine Chemicals

Complex organic molecules built to precise specification for synthesis and research applications.

VIEW APIs →
Vitamin D3 Analogues

Premium analogues for calcium regulation and specialized therapies.

VIEW APIs →

Products in Pipeline

Emerging molecules and innovative solutions under active development.

VIEW APIs →

–The D.K. Group Advantage

One partner, four specialized facilities

Projects can be routed to the group company best equipped for a given reaction, intermediate, or scale – not limited to a single site’s capability..
CDMO FACILITY
D.K. Pharma Tech Pvt. Ltd.
Dedicated CDMO facility specializing in hydrogenation and multi-reaction capability.
TARAPUR SITE
Sagitta Pvt. Ltd.
Advanced multi-step intermediates, specialized in high-pressure oxidation.
BIOTECHNOLOGY
D.K. Bio Pharma Pvt. Ltd.
Advancing into oncology therapeutics, including single-dose formulation R&D.
SUSTAINABILITY
Eco Green Industries Pvt. Ltd.
Recycling and biofuel production, supporting our clean chemistry commitments.
–LONG-TERM PARTNERS

Relationships measured in decades, not deliverables.

Teva

Sanofi

Bayer

Lonza

“Deals begin with handshakes, not signatures.”

D.K. Pharmachem · Founding Philosophy
–FOUR DECADES OF GROWTH

1980 to today

1980
Foundation
Founded by Dr. Rakesh Bakshi, starting with intermediates.
1985
Specialty Chemicals
Expanded into specialty and fine chemicals production.
1995
Advanced Intermediates
Introduced advanced intermediates for the global pharmaceutical industry.
2005
API Production
Began manufacturing APIs and bulk drug products.
2010
Vitamin D3
Added Vitamin D3 analogues to the product portfolio.
2013
Sagitta Pharma
Integrated Sagitta Pvt. Ltd., expanding production footprint.
2018
D.K. Bio Pharma
Welcomed D.K. Bio Pharma, strengthening the pipeline.
2023
New API Block
Built new API block, enhancing capacity and innovation.
2024
D.K. Pharma Tech
Launched D.K. Pharma Tech, advancing CDMO capability.

— CDMO & Contract Manufacturing Services

Four decades of process chemistry, built for your supply chain.

WHO-GMP certified manufacturer of APIs, advanced intermediates and specialty fine chemicals — trusted by Teva, Sanofi, Bayer and Lonza for 15–20 years running.